Go to the Globe and Mail homepage

Jump to main navigationJump to main content

1948 - Sunnybrook Veterans’ Hospital opens as the largest veterans’ hospital in Canada, standing as a symbol of the nation’s gratitude to its war veterans.William Lyon Mackenzie King visits to open the building. (Supplied)

1948 - Sunnybrook Veterans’ Hospital opens as the largest veterans’ hospital in Canada, standing as a symbol of the nation’s gratitude to its war veterans.William Lyon Mackenzie King visits to open the building.

(Supplied)

A Special Information Feature brought to you by Sunnybrook

Past, Present & Future Add to ...

2005
Scientists predict for the first time, using neuropsychological testing, which study participants will develop Alzheimer's disease within five or 10 years.

2006
Sunnybrook research finds that premenopausal women with HER2-positive breast cancer have better survival and lower recurrence rates when treated with anthracycline-based chemotherapy.

2007
Neuroimaging scientists discover the CT angiography “spot sign,” the first practical imaging method to identify the highest-risk stroke patients with bleeding into the brain. The finding has been adopted worldwide and forms the basis of a new emergency treatment protocol for stroke patients.

2007
Sunnybrook leads an international study that shows magnetic resonance imaging can improve the detection of hidden cancers in the opposite breast of women diagnosed with unilateral breast cancer.

2007
Discovery: the expression of a certain gene predicts which prostate cancer patients are at highest risk and therefore most likely to benefit from treatment.

2007
Sunnybrook launches the SHARE (Sexual Health and Rehabilitation) Clinic.

2007
Sunnybrook brain scientists are the first in the world to find and identify the fundamental waveform of dreaming sleep, providing possible links to learning and memory, potentially important for conditions such as stroke.

2008
The Canadian ALS Network becomes the first organized national network dedicated to developing and conducting clinical trials testing new ALS therapies. CALS continues under the direction of Sunnybrook Brain Sciences leaders.

2008
Sunnybrook researchers through the Crolla Research Unit and the Canadian Brain Tumour Consortium network, lead the world’s largest clinical trial testing the use of daily (metronomic) chemotherapy in relapsed brain cancer, establishing this therapy as the global standard for treatment.

2009
Researchers provide the first evidence showing what the H1N1 virus looks like and that it hits younger and healthier people harder. This enables hospitals in Canada and around the world to prepare for and treat "high-risk" patients effectively. 



2009
Sunnybrook’s Schulich Heart Centre is the first in Toronto to perform minimally invasive, beating-heart bypass surgery.

2009
Sunnybrook leads research in circadian rhythms and “clock genes,” illustrating that the timing of cancer treatment is important.

2009
Sunnybrook brain scientists are able to increase dreaming sleep by stimulating the area of the brain responsible for P-waves, advancing research using deep-brain recordings and stimulation to understand sleep, cognition and neurodegenerative disorders better.

2010
Sunnybrook launches the world's first dual-site-focused ultrasound surgery centre and tests the "scalpel-less" removal of uterine fibroids through high-intensity ultrasound, guided by MRI. Researchers in the centre will apply the technology, invented and commercialized by a Sunnybrook Research Institute scientist, to patients with breast, bone, head and neck, and rectal cancer.

2010
Researchers discover that a commonly prescribed antidepressant, paroxetine, interferes with tamoxifen therapy in women with breast cancer, and that other antidepressants of the same class do not.

2010
Drano for Arteries: Schulich Heart Centre leads the first small clinical trial of a new treatment (investigational drug MZ-004) for patients with blocked coronary arteries. The findings are poised to change the way patients are  treated, with a large multi-site, international clinical trial to begin later in 2013.

2011
Canada-first Rapid Results Prostate Biopsy Clinic launches to provide men with prostate cancer diagnosis within 72 hours versus the standard two- to three-week wait.

2012
Sunnybrook leads the first study comparing blood vessel functioning of teens with bipolar disorder and teens who are healthy, to better understand the link between bipolar disorder and heart disease.

2012
Researchers, in collaboration with the University of Toronto, develop the first prostate cancer screening device that uses nanotechnology and prostate cancer-specific biomarkers to identify and distinguish between slow-growing and aggressive cancers.

2012
Sunnybrook helps usher in a new era in advanced breast cancer treatment using a new way to attach chemotherapy directly to targeted therapy. The EMILIA global clinical trial of women with advanced HER2-positive breast cancer shows improved survival and significant reduced toxicity over standard treatment.

2012
St. John’s Rehab merges with Sunnybrook to build a comprehensive system of care, from acute care through to rehabilitation and recovery.

2013
Stroke specialists complete a world-first clinical trial demonstrating that a new method of home-based heart monitoring improves detection and treatment of one of the biggest risk factors for stroke, atrial fibrillation — a finding that could prevent thousands of strokes annually.

2013
Sunnybrook leads the Twin Birth Study, a nine-year international study, finding that delivering twins by planned vaginal birth is just as safe as delivering them by planned caesarean section, and that there is no significant difference in outcome between the two delivery methods.

2013
Sunnybrook shows for the first time that ultrasound can be used to monitor response of tumours as early as one week into chemotherapy in patients with locally advanced breast cancer. Standard PET or CAT scans typically take several months to determine treatment results.

 

Single page

Follow us on Twitter: @Globe_Health

 

Topics: